The Centrosome: A Target for Cancer Therapy

被引:14
作者
Mazzorana, M. [1 ]
Montoya, G. [1 ]
Mortuza, G. B. [1 ]
机构
[1] Ctr Nacl Invest Oncol CNIO, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain
关键词
Centrosome; cancer; targets; mitosis; cell cycle; microtubule; kinases; inhibitors; POLO-LIKE KINASE; AURORA-A KINASE; SMALL-MOLECULE INHIBITOR; PROTEIN-PROTEIN INTERACTIONS; CELL-CYCLE ARREST; GROWTH IN-VIVO; CENTRIOLE DUPLICATION; BREAST-CANCER; BOX DOMAIN; DNA-DAMAGE;
D O I
10.2174/156800911795655949
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The centrosome plays an essential role in cell cycle progression and cell polarity, organizing the microtubule network in interphase and mitosis. During cell division, the centrosome undergoes a series of structural and functional transitions and forms the two poles of the bipolar mitotic spindle. It is the microtubule cytoskeleton that is reorganized to form the two poles, ensuring accurate separation of the two daughter cells. To achieve this a large number of signalling proteins located at the centrosome, undergo precise time-dependent modulation. Protein kinases such as Aurora A, Polo and Neks, trigger and regulate events such as centrosome duplication, maturation and division. These enzymes are also involved in recruiting other proteins in cell division, thus they are likely to mediate the crosstalk between the cell and the centrosome cycle. In its function of microtubule organization, macromolecular complexes also have an important role. Tubulin polymerization confers the structural backbone to cell division, while other proteins may interact with it and/or mediate its recruitment to the centrosome. The interactions of these components regulate centrosome maturation and microtubule growth, essential mechanisms for cell division. Furthermore, dysregulation of this organelle, both at the level of signalling or as a structural element strongly correlates to aberrant proliferation, and the onset of tumours. Therefore, the centrosome represents an attractive target for anti-cancer therapy. Here we review the most important centrosomal proteins and their therapeutic potential. In addition, we summarize the current strategies of intervention and report the present stage of anticancer drug development targeting the centrosome.
引用
收藏
页码:600 / 612
页数:13
相关论文
共 148 条
[21]   The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex [J].
Cheng, KY ;
Lowe, ED ;
Sinclair, J ;
Nigg, EA ;
Johnson, LN .
EMBO JOURNAL, 2003, 22 (21) :5757-5768
[22]   TACC1-chTOG-Aurora A protein complex in breast cancer [J].
Conte, N ;
Delaval, B ;
Ginestier, C ;
Ferrand, A ;
Isnardon, D ;
Larroque, C ;
Prigent, C ;
Séraphin, B ;
Jacquemier, J ;
Birnbaum, D .
ONCOGENE, 2003, 22 (50) :8102-8116
[23]   The SCF/Slimb Ubiquitin Ligase Limits Centrosome Amplification through Degradation of SAK/PLK4 [J].
Cunha-Ferreira, Ines ;
Rodrigues-Martins, Ana ;
Bento, Ines ;
Riparbelli, Maria ;
Zhang, Wei ;
Laue, Ernest ;
Callaini, Giuliano ;
Glover, David M. ;
Bettencourt-Dias, Monica .
CURRENT BIOLOGY, 2009, 19 (01) :43-49
[24]  
Dai W, 2002, INT J ONCOL, V20, P121
[25]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[26]   Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity [J].
De Luca, M. ;
Brunetto, L. ;
Asteriti, I. A. ;
Giubettini, M. ;
Lavia, P. ;
Guarguaglini, G. .
ONCOGENE, 2008, 27 (51) :6539-6549
[27]   Interaction of the mitotic inhibitor monastrol with human kinesin Eg5 [J].
DeBonis, S ;
Simorre, JP ;
Crevel, I ;
Lebeau, L ;
Skoufias, DA ;
Blangy, A ;
Ebel, C ;
Gans, P ;
Cross, R ;
Hackney, DD ;
Wade, RH ;
Kozielski, F .
BIOCHEMISTRY, 2003, 42 (02) :338-349
[28]   Unraveling hot spots in binding interfaces: progress and challenges [J].
DeLano, WL .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (01) :14-20
[29]   Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores [J].
Ditchfield, C ;
Johnson, VL ;
Tighe, A ;
Ellston, R ;
Haworth, C ;
Johnson, T ;
Mortlock, A ;
Keen, N ;
Taylor, SS .
JOURNAL OF CELL BIOLOGY, 2003, 161 (02) :267-280
[30]   Active cyclin A CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas [J].
Dobashi, Y ;
Shoji, M ;
Jiang, SX ;
Kobayashi, M ;
Kawakubo, Y ;
Kameya, T .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :963-972